This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on Oct 23 to consider Q2/H1 FY26 results
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 2.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals has informed BSE and NSE that its Board of Directors will meet on Friday, October 23, 2026 to consider and approve the unaudited financial results (standalone and consolidated) along with the limited review report for the quarter and half year ended September 30, 2026. The company also confirmed that the trading window for designated persons remains closed until 48 hours after the results are declared.
Routine procedural notice ahead of Q2 FY26 results. Watch the actual results on or after Oct 23 for earnings performance and any management commentary.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹456.5 Cr | ₹393.6 Cr | +16.0% |
| Operating profit | ₹64.54 Cr | ₹62.95 Cr | +2.5% |
| Profit after tax | ₹56.36 Cr | ₹57.48 Cr | −1.9% |
| EBITDA margin | 23.4% | 23.4% | −0.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.